Kurkinen M, Daly T (2024) Survival time in Alzheimer’s disease: an overlooked measure of safety and efficacy of disease-modifying therapies. Adv Clin Exp Med, in press
Daly T, Kurkinen M (2024) Measuring our language about anti-amyloid antibodies in Alzheimer’s disease: technical, theoretical, and lay language considerations. Clin Neurol Neurosurg 241:108314
Kurkinen M (2024) Anti-amyloid therapies do not slow Alzheimer’s disease progression. Dementia Neuropsychol 17:e20230099
Kurkinen M (2023) Donanemab: Not two without a third. Add Clin Exp Med 32, 1085–1087
Kurkinen M (2023) Lecanemab (Leqembi) is not the right drug for patients with Alzheimer’s disease. Adv Clin Exp Med 32, 943–947
Kurkinen M, Fułek M, Fułek K, Beszłej JA, Kurpas D, Leszek J (2023) The amyloid cascade hypothesis in Alzheimer’s disease: Should we change our thinking? Biomolecules 13, 453
Kurkinen M (2022) Astrocyte glutamate transporter EAAT2 in Alzheimer dementia. Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments (Zoran Pavlovic, Ed.) Springer Nature, Berlin, Germany, pp. 229–260
Kurkinen M, Tran L (2021) Aduhelm: The best hope for Alzheimer’s patients or the worst decision the FDA ever made? J Alzheimers Dis 84, 969-971
Kurkinen M (2021) Alzheimer’s trials: A cul-de-sac with no end in sight. Adv Clin Exp Med 30, 653-654
Kurkinen M (2018) Alzheimer’s dementia drug discovery: targeting astrocyte glutamate uptake. Conn’s Handbook of Models for Human Aging, 2nd Ed (Ronald Conn and Jeffrey Ram, Eds.) Elsevier, pp. 587-591
Kurkinen M (2017) The amyloid hypothesis is too good to be true. Alzheimers Dement Cogn Neurol 1, 1-9
March 9, 2017, Detroit, USA Wayne State University School of Medicine, Department of Physiology Alzheimer’s drug discovery: Wo Sind die Magischen Kugeln?
June 22-24, 2017, Copenhagen, Denmark 13th World Federation of Societies of Biological Psychiatry Alzheimer’s drug discovery: targeting synaptic glutamate uptake
August 27-September 2, Naples-Florence, Italy Congress on Invertebrate Models of Human Aging Alzheimer’s drug discovery: targeting synaptic glutamate uptake
September 20, 2018, Stockport, UK The Meadows Hospital Alzheimer’s drug discovery and clinical development
September 24-25, 2018, London, UK Dementia and Dementia Care Alzheimer’s drug discovery: targeting synaptic glutamate uptake
January 30, 2019, Stockport, UK Vascular Dementia Conference Microvascular events in development of dementia
February 18-21, 2019, San Francisco, USA Alzheimer Society International Congress (ASIC) Alzheimer drugs: targeting synaptic glutamate uptake
February 21-24, 2019, Sydney, Australia 7th World Congress of Asian Psychiatry (WCAP) Alzheimer drugs: targeting synaptic glutamate uptake
November 29-30, 2019, Wroclaw, Poland 13th International Conference of Psychogeriatrics 2019: State of Art Alzheimer’s drugs: targeting synaptic glutamate uptake
March 9, 2017, Detroit, USA Wayne State University School of Medicine, Department of Physiology Alzheimer’s drug discovery: Wo Sind die Magischen Kugeln?
June 22-24, 2017, Copenhagen, Denmark 13th World Federation of Societies of Biological Psychiatry Alzheimer’s drug discovery: targeting synaptic glutamate uptake
August 27-September 2, Naples-Florence, Italy Congress on Invertebrate Models of Human Aging Alzheimer’s drug discovery: targeting synaptic glutamate uptake
September 20, 2018, Stockport, UK The Meadows Hospital Alzheimer’s drug discovery and clinical development
September 24-25, 2018, London, UK Dementia and Dementia Care Alzheimer’s drug discovery: targeting synaptic glutamate uptake
January 30, 2019, Stockport, UK Vascular Dementia Conference Microvascular events in development of dementia
February 18-21, 2019, San Francisco, USA Alzheimer Society International Congress (ASIC) Alzheimer drugs: targeting synaptic glutamate uptake
February 21-24, 2019, Sydney, Australia 7th World Congress of Asian Psychiatry (WCAP) Alzheimer drugs: targeting synaptic glutamate uptake
November 29-30, 2019, Wroclaw, Poland 13th International Conference of Psychogeriatrics 2019: State of Art Alzheimer’s drugs: targeting synaptic glutamate uptake
March 9, 2017, Detroit, USA Wayne State University School of Medicine, Department of Physiology Alzheimer’s drug discovery: Wo Sind die Magischen Kugeln?
June 22-24, 2017, Copenhagen, Denmark 13th World Federation of Societies of Biological Psychiatry Alzheimer’s drug discovery: targeting synaptic glutamate uptake
August 27-September 2, Naples-Florence, Italy Congress on Invertebrate Models of Human Aging Alzheimer’s drug discovery: targeting synaptic glutamate uptake
September 20, 2018, Stockport, UK The Meadows Hospital Alzheimer’s drug discovery and clinical development
September 24-25, 2018, London, UK Dementia and Dementia Care Alzheimer’s drug discovery: targeting synaptic glutamate uptake
January 30, 2019, Stockport, UK Vascular Dementia Conference Microvascular events in development of dementia
February 18-21, 2019, San Francisco, USA Alzheimer Society International Congress (ASIC) Alzheimer drugs: targeting synaptic glutamate uptake
February 21-24, 2019, Sydney, Australia 7th World Congress of Asian Psychiatry (WCAP) Alzheimer drugs: targeting synaptic glutamate uptake
November 29-30, 2019, Wroclaw, Poland 13th International Conference of Psychogeriatrics 2019: State of Art Alzheimer’s drugs: targeting synaptic glutamate uptake